{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:05:59Z","timestamp":1769263559426,"version":"3.49.0"},"reference-count":18,"publisher":"American Society for Clinical Investigation","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Invest."],"published-print":{"date-parts":[[2010,5,3]]},"DOI":"10.1172\/jci43030","type":"journal-article","created":{"date-parts":[[2010,4,27]],"date-time":"2010-04-27T14:02:05Z","timestamp":1272376925000},"page":"1392-1395","source":"Crossref","is-referenced-by-count":8,"title":["Caveat mTOR: aberrant signaling disrupts corticogenesis"],"prefix":"10.1172","volume":"120","author":[{"given":"Lucy R.","family":"Osborne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"232","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.31887\/DCNS.2008.10.1\/rjleventer","volume":"10","author":"Leventer","year":"2008","journal-title":"Dialogues Clin Neurosci."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm100"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/ng1494"},{"key":"B4","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI41592","volume":"120","author":"Orlova","year":"2010","journal-title":"J Clin Invest."},{"key":"B5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbapap.2009.12.001","volume":"1804","author":"Dowling","year":"2010","journal-title":"Biochim Biophys Acta."},{"key":"B6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.mrrev.2008.06.001","volume":"659","author":"Rosner","year":"2008","journal-title":"Mutat Res."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg490"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.03.025"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1938-07.2007"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1242\/dev.041459"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20784"},{"key":"B12","unstructured":"Koenig MK, Northrup H. Topical rapamycin therapy to alleviate cutaneous manifestations of tuberous sclerosis complex (TSC) and neurofibromatosis I (NF1). http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01031901 ."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.002386"},{"key":"B14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann Neurol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nm1788"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nn1566"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0066-09.2009"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4179-08.2009"}],"container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jci.org\/articles\/view\/43030\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T17:18:45Z","timestamp":1691083125000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jci.org\/articles\/view\/43030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,3]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5,3]]}},"URL":"https:\/\/doi.org\/10.1172\/jci43030","relation":{},"ISSN":["0021-9738"],"issn-type":[{"value":"0021-9738","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5,3]]}}}